I was in Brussels recently, where I visited the European Parliament, which got me thinking about the impact on clinical research that comes about as a result of government organizations around the world setting the regulations for how trials should be run.

It can often seem as though those regulations are designed to ensure a potential treatment fails the trial. And in some ways that makes perfect sense.

What we’re doing when studying the efficacy of potential new treatments, is essentially getting volunteers to expose themselves to something that could be harmful to them.

So, yes, it makes sense to try and ensure from a regulatory perspective that most potential treatments fail at the trial stage. Not because we want to restrict the development of new treatments, but because we want to ensure the only treatments released to the public are the ones that will do the least harm.

You may also like

Any Idiot can do Patient Recruitment
I was chatting with a fellow patient recruitment specialist recently, and he used the phrase ‘any idiot can do patient recruitment’. I won’t reel off the list of names that came into my head ...
You Should have Respect for the Disease and the Patient Recruitment Process Itself
Respect for the disease or condition that the potential treatment is designed to work on is another essential factor. When I talk about respect in this regard, I mean being aware of the ...
Showing Respect for All the Stakeholders in the Patient Recruitment Process
Respect for the other stakeholders in the field of patient recruitment is based on recognizing that everyone is fundamentally trying to do the best they can. There is often a finger pointing ...